In addition, the TyG index, which is regarded as an indicator related to IR, has also shown a U-shaped doseresponse relationship in the prediction of diabetes, although the inflection point may vary across different metabolic backgrounds (174, 175)
A real answer for the client who whispers the question
Ozempic is still the GLP-1 king, but Lilly is rapidly gaining market share, with its Q2 2024 sales reaching $3.01 billion compared to Novo Nordisks $5.38 billion
Wegovy, which contains the active ingredient semaglutide, is one of the prescription medications we offer for chronic weight management
Major payers including Aetna, Cigna, Elevance Health, Humana, UnitedHealthcare and Wellcare also released their MA offerings for 2025, as previously reported by Fierce Healthcare
Inhibition of jnk signaling attenuates photoreceptor ferroptosis caused by all-trans-retinal